Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

B3GAT3 anticorps (AA 1-335)

Cet anticorps anti-B3GAT3 est un anticorps Souris Polyclonal détectant B3GAT3 dans WB. Adapté pour Humain. Ce Primary Antibody a été cité dans 4+ publications.
N° du produit ABIN525639

Aperçu rapide pour B3GAT3 anticorps (AA 1-335) (ABIN525639)

Antigène

Voir toutes B3GAT3 Anticorps
B3GAT3 (beta-1,3-Glucuronyltransferase 3 (Glucuronosyltransferase I) (B3GAT3))

Reactivité

  • 18
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 14
  • 4
Souris

Clonalité

  • 16
  • 2
Polyclonal

Conjugué

  • 13
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp B3GAT3 est non-conjugé

Application

  • 18
  • 10
  • 1
Western Blotting (WB)
  • Épitope

    • 8
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 1-335

    Fonction

    Mouse polyclonal antibody raised against a full-length human B3GAT3 protein.

    Séquence

    MKLKLKNVFL AYFLVSIAGL LYALVQLGQP CDCLPPLRAA AEQLRQKDLR ISQLQAELRR PPPAPAQPPE PEALPTIYVV TPTYARLVQK AELVRLSQTL SLVPRLHWLL VEDAEGPTPL VSGLLAASGL LFTHLVVLTP KAQRLREGEP GWVHPRGVEQ RNKALDWLRG RGGAVGGEKD PPPPGTQGVV YFADDDNTYS RELFEEMRWT RGVSVWPVGL VGGLRFEGPQ VQDGRVVGFH TAWEPSRPFP VDMAGFAVAL PLLLDKPNAQ FDSTAPRGHL ESSLLSHLVD PKDLEPRAAN CTRVLVWHTR TEKPKMKQEE QLQRQGRGSD PAIEV

     Réactivité croisée

    Humain

    Attributs du produit

    Antibody reactive against mammalian transfected lysate.

    Immunogène

    B3GAT3 (NP_036332.2, 1 a.a. ~ 335 a.a) full-length human protein.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Buffer

    In 1x PBS, pH 7.4

    Conseil sur la manipulation

    Aliquot to avoid repeated freezing and thawing.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
  • Job, Mizumoto, Smith, Couser, Brazil, Saal, Patterson, Gibson, Soden, Miller, Thiffault, Saunders, Yamada, Hoffmann, Sugahara, Farrow: "Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype." dans: BMC medical genetics, Vol. 17, Issue 1, pp. 86, (2016) (PubMed).

    Budde, Mizumoto, Kogawa, Becker, Altmüller, Thiele, Rüschendorf, Toliat, Kaleschke, Hämmerle, Höhne, Sugahara, Nürnberg, Kennerknecht: "Skeletal dysplasia in a consanguineous clan from the island of Nias/Indonesia is caused by a novel mutation in B3GAT3." dans: Human genetics, Vol. 134, Issue 7, pp. 691-704, (2015) (PubMed).

    Baasanjav, Al-Gazali, Hashiguchi, Mizumoto, Fischer, Horn, Seelow, Ali, Aziz, Langer, Saleh, Becker, Nürnberg, Cantagrel, Gleeson, Gomez, Michel, Stricker, Lindner, Nürnberg, Sugahara, Mundlos et al.: "Faulty initiation of proteoglycan synthesis causes cardiac and joint defects. ..." dans: American journal of human genetics, Vol. 89, Issue 1, pp. 15-27, (2011) (PubMed).

    Hiyama, Gajghate, Sakai, Mochida, Shapiro, Risbud: "Activation of TonEBP by calcium controls {beta}1,3-glucuronosyltransferase-I expression, a key regulator of glycosaminoglycan synthesis in cells of the intervertebral disc." dans: The Journal of biological chemistry, Vol. 284, Issue 15, pp. 9824-34, (2009) (PubMed).

  • Antigène

    B3GAT3 (beta-1,3-Glucuronyltransferase 3 (Glucuronosyltransferase I) (B3GAT3))

    Autre désignation

    B3GAT3

    Sujet

    Full Gene Name: beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)
    Synonyms: GLCATI,GlcAT-I

    ID gène

    26229

    NCBI Accession

    NM_012200

    Pathways

    Glycosaminoglycan Metabolic Process
Vous êtes ici:
Chat with us!